Literature DB >> 30138088

CUA-AUA International Fellows Program: San Francisco 2018.

Madhur Nayan1.   

Abstract

Year:  2018        PMID: 30138088      PMCID: PMC6114168          DOI: 10.5489/cuaj.5500

Source DB:  PubMed          Journal:  Can Urol Assoc J        ISSN: 1911-6470            Impact factor:   1.862


× No keyword cloud information.
  13 in total

1.  Beta-blocker use is associated with improved relapse-free survival in patients with triple-negative breast cancer.

Authors:  Amal Melhem-Bertrandt; Mariana Chavez-Macgregor; Xiudong Lei; Erika N Brown; Richard T Lee; Funda Meric-Bernstam; Anil K Sood; Suzanne D Conzen; Gabriel N Hortobagyi; Ana-Maria Gonzalez-Angulo
Journal:  J Clin Oncol       Date:  2011-05-31       Impact factor: 44.544

2.  The risk of cancer in users of statins.

Authors:  Matthijs R Graaf; Annette B Beiderbeck; Antoine C G Egberts; Dick J Richel; Henk-Jan Guchelaar
Journal:  J Clin Oncol       Date:  2004-06-15       Impact factor: 44.544

3.  Canadian consensus guidelines for the management of testicular germ cell cancer.

Authors:  Lori Wood; Christian Kollmannsberger; Michael Jewett; Peter Chung; Sebastian Hotte; Martin O'Malley; Joan Sweet; Lynn Anson-Cartwright; Eric Winquist; Scott North; Scott Tyldesley; Jeremy Sturgeon; Mary Gospodarowicz; Roanne Segal; Tina Cheng; Peter Venner; Malcolm Moore; Peter Albers; Robert Huddart; Craig Nichols; Padraig Warde
Journal:  Can Urol Assoc J       Date:  2010-04       Impact factor: 1.862

4.  Statin use and reduced cancer-related mortality.

Authors:  Sune F Nielsen; Børge G Nordestgaard; Stig E Bojesen
Journal:  N Engl J Med       Date:  2012-11-08       Impact factor: 91.245

Review 5.  The current evidence on statin use and prostate cancer prevention: are we there yet?

Authors:  Mahmoud A Alfaqih; Emma H Allott; Robert J Hamilton; Michael R Freeman; Stephen J Freedland
Journal:  Nat Rev Urol       Date:  2016-10-25       Impact factor: 14.432

Review 6.  Aspirin and cancer risk: a quantitative review to 2011.

Authors:  C Bosetti; V Rosato; S Gallus; J Cuzick; C La Vecchia
Journal:  Ann Oncol       Date:  2012-04-19       Impact factor: 32.976

7.  Evaluation of long-term toxicity after chemotherapy for testicular cancer.

Authors:  C Bokemeyer; C C Berger; M A Kuczyk; H J Schmoll
Journal:  J Clin Oncol       Date:  1996-11       Impact factor: 44.544

8.  Statins and the risk of colorectal cancer.

Authors:  Jenny N Poynter; Stephen B Gruber; Peter D R Higgins; Ronit Almog; Joseph D Bonner; Hedy S Rennert; Marcelo Low; Joel K Greenson; Gad Rennert
Journal:  N Engl J Med       Date:  2005-05-26       Impact factor: 91.245

9.  Do inhibitors of angiotensin-I-converting enzyme protect against risk of cancer?

Authors:  A F Lever; D J Hole; C R Gillis; I R McCallum; G T McInnes; P L MacKinnon; P A Meredith; L S Murray; J L Reid; J W Robertson
Journal:  Lancet       Date:  1998-07-18       Impact factor: 79.321

Review 10.  Radiotherapy or chemotherapy for clinical stage IIA and IIB seminoma: a systematic review and meta-analysis of patient outcomes.

Authors:  P Giannatempo; T Greco; L Mariani; N Nicolai; S Tana; E Farè; D Raggi; L Piva; M Catanzaro; D Biasoni; T Torelli; S Stagni; B Avuzzi; M Maffezzini; G Landoni; F De Braud; A M Gianni; G Sonpavde; R Salvioni; A Necchi
Journal:  Ann Oncol       Date:  2014-09-11       Impact factor: 32.976

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.